{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T04:43:59Z","timestamp":1788669839824,"version":"build-2803163510"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T00:00:00Z","timestamp":1729641600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T00:00:00Z","timestamp":1729641600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100021856","name":"Ministero dell'Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["5x1000-2023"],"award-info":[{"award-number":["5x1000-2023"]}],"id":[{"id":"10.13039\/501100021856","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004710","name":"Fondazione Umberto Veronesi","doi-asserted-by":"publisher","award":["2023"],"award-info":[{"award-number":["2023"]}],"id":[{"id":"10.13039\/501100004710","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Italian Musculoskeletal Apparatus Network RAMS","award":["RAMS"],"award-info":[{"award-number":["RAMS"]}]},{"DOI":"10.13039\/501100003196","name":"Italian Ministry of Health","doi-asserted-by":"crossref","award":["Current Research funds-2023"],"award-info":[{"award-number":["Current Research funds-2023"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-75747-w","type":"journal-article","created":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T04:02:52Z","timestamp":1729656172000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Effects of coagulation factors on bone cells and consequences of their absence in haemophilia a patients"],"prefix":"10.1038","volume":"14","author":[{"given":"Giulia","family":"Battafarano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Lancellotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Sacco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Terreri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacopo","family":"Di Gregorio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Di Giuseppe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"D\u2019Agostini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ottavia","family":"Porzio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Di Gennaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maira","family":"Tardugno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Pelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Minisola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renato Maria","family":"Toniolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Luciani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Del Fattore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raimondo","family":"De Cristofaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,23]]},"reference":[{"key":"75747_CR1","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1111\/jth.12317","volume":"11","author":"M Escobar","year":"2013","unstructured":"Escobar, M., Sallah, S. & Hemophilia A and hemophilia B: focus on arthropathy and variables affecting bleeding severity and prophylaxis. J. Thromb. Haemost. 11, 1449\u20131453. https:\/\/doi.org\/10.1111\/jth.12317 (2013).","journal-title":"J. Thromb. Haemost"},{"issue":"Suppl 2","key":"75747_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2516.2011.02615.x","volume":"17","author":"EC Rodriguez-Merchan","year":"2011","unstructured":"Rodriguez-Merchan, E. C. et al. Joint protection in haemophilia. Haemophilia. 17 (Suppl 2), 1\u201323. https:\/\/doi.org\/10.1111\/j.1365-2516.2011.02615.x (2011).","journal-title":"Haemophilia"},{"key":"75747_CR3","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1111\/hae.12006","volume":"19","author":"D Stephensen","year":"2013","unstructured":"Stephensen, D. & Rodriguez-Merchan, E. C. Orthopaedic co-morbidities in the elderly haemophilia population: a review. Haemophilia. 19, 166\u2013173. https:\/\/doi.org\/10.1111\/hae.12006 (2013).","journal-title":"Haemophilia"},{"key":"75747_CR4","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1080\/17474086.2021.1977118","volume":"14","author":"EC Rodriguez-Merchan","year":"2021","unstructured":"Rodriguez-Merchan, E. C. Hemophilic arthropathy: a teaching approach devoted to hemophilia treaters in under-development countries. Expert Rev. Hematol. 14, 887\u2013896. https:\/\/doi.org\/10.1080\/17474086.2021.1977118 (2021).","journal-title":"Expert Rev. Hematol."},{"key":"75747_CR5","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.blre.2019.03.002","volume":"35","author":"B Samuelson Bannow","year":"2019","unstructured":"Samuelson Bannow, B. et al. Long-established role in haemophilia A and emerging evidence beyond haemostasis. Blood Rev. 35, 43\u201350. https:\/\/doi.org\/10.1016\/j.blre.2019.03.002 (2019). Factor VIII.","journal-title":"Blood Rev."},{"key":"75747_CR6","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1302\/0301-620X.80B2.0800191","volume":"80","author":"EC Rodriguez-Merchan","year":"1998","unstructured":"Rodriguez-Merchan, E. C. Management of the orthopaedic complications of haemophilia. J. Bone Joint Surg. Br. 80, 191\u2013196 (1998).","journal-title":"J. Bone Joint Surg. Br."},{"key":"75747_CR7","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1111\/bjh.13312","volume":"170","author":"ND Gay","year":"2015","unstructured":"Gay, N. D. et al. Increased fracture rates in people with haemophilia: a 10-year single institution retrospective analysis. Br. J. Haematol. 170, 584\u2013586. https:\/\/doi.org\/10.1111\/bjh.13312 (2015).","journal-title":"Br. J. Haematol."},{"key":"75747_CR8","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1160\/TH09-09-0629","volume":"103","author":"A Iorio","year":"2010","unstructured":"Iorio, A., Fabbriciani, G., Marcucci, M., Brozzetti, M. & Filipponi, P. Bone mineral density in haemophilia patients. A meta-analysis. Thromb. Haemost. 103, 596\u2013603. https:\/\/doi.org\/10.1160\/TH09-09-0629 (2010).","journal-title":"Thromb. Haemost"},{"key":"75747_CR9","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1111\/hae.12736","volume":"21","author":"CL Kempton","year":"2015","unstructured":"Kempton, C. L., Antoniucci, D. M. & Rodriguez-Merchan, E. C. Bone health in persons with haemophilia. Haemophilia. 21, 568\u2013577. https:\/\/doi.org\/10.1111\/hae.12736 (2015).","journal-title":"Haemophilia"},{"key":"75747_CR10","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1160\/TH11-08-05563","volume":"107","author":"P Anagnostis","year":"2012","unstructured":"Anagnostis, P. et al. Reduced bone mineral density in patients with haemophilia A and B in Northern Greece. Thromb. Haemost. 107, 545\u2013551. https:\/\/doi.org\/10.1160\/TH11-08-05563 (2012).","journal-title":"Thromb. Haemost"},{"key":"75747_CR11","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/hae.12240","volume":"20","author":"CL Kempton","year":"2014","unstructured":"Kempton, C. L. et al. Bone density in haemophilia: a single institutional cross-sectional study. Haemophilia. 20, 121\u2013128. https:\/\/doi.org\/10.1111\/hae.12240 (2014).","journal-title":"Haemophilia"},{"key":"75747_CR12","first-page":"181","volume":"87","author":"SJ Gallacher","year":"1994","unstructured":"Gallacher, S. J. et al. Association of severe haemophilia A with osteoporosis: a densitometric and biochemical study. Q. J. Med. 87, 181\u2013186 (1994).","journal-title":"Q. J. Med."},{"key":"75747_CR13","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1111\/hae.12195","volume":"19","author":"M Recht","year":"2013","unstructured":"Recht, M., Liel, M. S., Turner, R. T., Klein, R. F. & Taylor, J. A. The bone disease associated with factor VIII deficiency in mice is secondary to increased bone resorption. Haemophilia. 19, 908\u2013912. https:\/\/doi.org\/10.1111\/hae.12195 (2013).","journal-title":"Haemophilia"},{"key":"75747_CR14","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1002\/jbmr.3469","volume":"33","author":"D Lu","year":"2018","unstructured":"Lu, D. et al. LRP1 suppresses bone resorption in mice by inhibiting the RANKL-Stimulated NF-kappaB and p38 pathways during osteoclastogenesis. J. Bone Min. Res. 33, 1773\u20131784. https:\/\/doi.org\/10.1002\/jbmr.3469 (2018).","journal-title":"J. Bone Min. Res."},{"key":"75747_CR15","doi-asserted-by":"publisher","first-page":"794456","DOI":"10.3389\/fmed.2022.794456","volume":"9","author":"J Gebetsberger","year":"2022","unstructured":"Gebetsberger, J., Schirmer, M., Wurzer, W. J. & Streif, W. Low bone Mineral Density in Hemophiliacs. Front. Med. (Lausanne). 9, 794456. https:\/\/doi.org\/10.3389\/fmed.2022.794456 (2022).","journal-title":"Front. Med. (Lausanne)"},{"key":"75747_CR16","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s11657-022-01203-9","volume":"18","author":"X Lin","year":"2023","unstructured":"Lin, X. et al. Pathogenesis and treatment of osteoporosis in patients with hemophilia. Arch. Osteoporos. 18, 17. https:\/\/doi.org\/10.1007\/s11657-022-01203-9 (2023).","journal-title":"Arch. Osteoporos."},{"key":"75747_CR17","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1055\/a-1972-8983","volume":"43","author":"AC Strauss","year":"2023","unstructured":"Strauss, A. C. et al. Osteoporosis remains constant in patients with hemophilia-long-term course in consideration of comorbidities. Hamostaseologie. 43, 208\u2013214. https:\/\/doi.org\/10.1055\/a-1972-8983 (2023).","journal-title":"Hamostaseologie"},{"key":"75747_CR18","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1186\/s12891-023-06795-y","volume":"24","author":"D Wu","year":"2023","unstructured":"Wu, D. & Shen, S. Osteoporosis and associated risk factors in patients with severe hemophilia A: a case-control study from China. BMC Musculoskelet. Disord. 24, 657. https:\/\/doi.org\/10.1186\/s12891-023-06795-y (2023).","journal-title":"BMC Musculoskelet. Disord"},{"key":"75747_CR19","doi-asserted-by":"publisher","unstructured":"Wells, A. J. et al. A case-control study assessing bone mineral density in severe haemophilia A in the UK. Haemophilia  21, 109\u2013115. https:\/\/doi.org\/10.1111\/hae.12565 (2015).","DOI":"10.1111\/hae.12565"},{"key":"75747_CR20","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1111\/j.1365-2516.2011.02587.x","volume":"18","author":"B Alioglu","year":"2012","unstructured":"Alioglu, B. et al. Evaluation of bone mineral density in Turkish children with severe haemophilia A: Ankara hospital experience. Haemophilia. 18, 69\u201374. https:\/\/doi.org\/10.1111\/j.1365-2516.2011.02587.x (2012).","journal-title":"Haemophilia"},{"key":"75747_CR21","doi-asserted-by":"crossref","unstructured":"Baud\u2019huin, M. et al. Factor VIII-von willebrand factor Complex inhibits Osteoclastogenesis and Controls Cell Survival. J. Biol. Chem. 284, https:\/\/doi.org\/10.1074\/jbc.M109.030312 (2009).","DOI":"10.1074\/jbc.M109.030312"},{"key":"75747_CR22","doi-asserted-by":"publisher","unstructured":"Pai, Y. Y. et al. Risk of fractures, repeated fractures and osteoporotic fractures among patients with Hemophilia in Taiwan: a 14-Year Population-based Cohort Study. Int. J. Environ. Res. Public. Health. 20. https:\/\/doi.org\/10.3390\/ijerph20010525 (2022).","DOI":"10.3390\/ijerph20010525"},{"key":"75747_CR23","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1111\/hae.14487","volume":"28","author":"J Klintman","year":"2022","unstructured":"Klintman, J., Akesson, K. E., Holme, P. A. & Fischer, K. Bone mineral density in haemophilia - a multicentre study evaluating the impact of different replacement regimens. Haemophilia. 28, 239\u2013246. https:\/\/doi.org\/10.1111\/hae.14487 (2022).","journal-title":"Haemophilia"},{"key":"75747_CR24","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1080\/17474086.2022.2108783","volume":"15","author":"EC Rodriguez-Merchan","year":"2022","unstructured":"Rodriguez-Merchan, E. C. Osteoporosis in hemophilia: what is its importance in clinical practice? Expert Rev. Hematol. 15, 697\u2013710. https:\/\/doi.org\/10.1080\/17474086.2022.2108783 (2022).","journal-title":"Expert Rev. Hematol."},{"key":"75747_CR25","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s00277-009-0759-x","volume":"89","author":"O Katsarou","year":"2010","unstructured":"Katsarou, O. et al. Increased bone resorption is implicated in the pathogenesis of bone loss in hemophiliacs: correlations with hemophilic arthropathy and HIV infection. Ann. Hematol. 89, 67\u201374. https:\/\/doi.org\/10.1007\/s00277-009-0759-x (2010).","journal-title":"Ann. Hematol."},{"key":"75747_CR26","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1097\/MBC.0000000000000237","volume":"26","author":"C Albayrak","year":"2015","unstructured":"Albayrak, C. & Albayrak, D. Vitamin D levels in children with severe hemophilia A: an underappreciated deficiency. Blood Coagul Fibrinolysis. 26, 285\u2013289. https:\/\/doi.org\/10.1097\/MBC.0000000000000237 (2015).","journal-title":"Blood Coagul Fibrinolysis"},{"key":"75747_CR27","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1111\/j.1365-2516.2012.02899.x","volume":"19","author":"S Linari","year":"2013","unstructured":"Linari, S. et al. Hypovitaminosis D and osteopenia\/osteoporosis in a haemophilia population: a study in HCV\/HIV or HCV infected patients. Haemophilia. 19, 126\u2013133. https:\/\/doi.org\/10.1111\/j.1365-2516.2012.02899.x (2013).","journal-title":"Haemophilia"},{"key":"75747_CR28","doi-asserted-by":"publisher","first-page":"206","DOI":"10.17305\/bjbms.2018.2335","volume":"18","author":"M Dagli","year":"2018","unstructured":"Dagli, M. et al. Evaluation of bone mineral density (BMD) and indicators of bone turnover in patients with hemophilia. Bosn J. Basic. Med. Sci. 18, 206\u2013210. https:\/\/doi.org\/10.17305\/bjbms.2018.2335 (2018).","journal-title":"Bosn J. Basic. Med. Sci."},{"key":"75747_CR29","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/hae.13986","volume":"27","author":"G Goldscheitter","year":"2021","unstructured":"Goldscheitter, G., Recht, M., Sochacki, P., Manco-Johnson, M. & Taylor, J. A. Biomarkers of bone disease in persons with haemophilia. Haemophilia. 27, 149\u2013155. https:\/\/doi.org\/10.1111\/hae.13986 (2021).","journal-title":"Haemophilia"},{"key":"75747_CR30","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.3899\/jrheum.120370","volume":"39","author":"D Melchiorre","year":"2012","unstructured":"Melchiorre, D. et al. RANK-RANKL-OPG in hemophilic arthropathy: from clinical and imaging diagnosis to histopathology. J. Rheumatol. 39, 1678\u20131686. https:\/\/doi.org\/10.3899\/jrheum.120370 (2012).","journal-title":"J. Rheumatol."},{"key":"75747_CR31","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3897\/folmed.65.e75414","volume":"65","author":"HA Ivanova","year":"2023","unstructured":"Ivanova, H. A., Grudeva-Popova, Z., Deneva, T., Tsvetkova, S. & Mateva, N. A single-center study of bone mineral density in adult patients with severe hemophilia A in correlation with markers of bone metabolism. Folia Med. (Plovdiv). 65, 87\u201392. https:\/\/doi.org\/10.3897\/folmed.65.e75414 (2023).","journal-title":"Folia Med. (Plovdiv)"},{"key":"75747_CR32","doi-asserted-by":"publisher","unstructured":"Alito, A. et al. Haemophilia and Fragility fractures: from pathogenesis to Multidisciplinary Approach. Int. J. Mol. Sci. 24. https:\/\/doi.org\/10.3390\/ijms24119395 (2023).","DOI":"10.3390\/ijms24119395"},{"key":"75747_CR33","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1530\/JME-12-0177","volume":"50","author":"S Sivagurunathan","year":"2013","unstructured":"Sivagurunathan, S. et al. Thrombin inhibits osteoclast differentiation through a non-proteolytic mechanism. J. Mol. Endocrinol. 50, 347\u2013359. https:\/\/doi.org\/10.1530\/JME-12-0177 (2013).","journal-title":"J. Mol. Endocrinol."},{"key":"75747_CR34","doi-asserted-by":"publisher","first-page":"R23","DOI":"10.1186\/ar2616","volume":"11","author":"R Lari","year":"2009","unstructured":"Lari, R., Kitchener, P. D. & Hamilton, J. A. The proliferative human monocyte subpopulation contains osteoclast precursors. Arthritis Res. Ther. 11, R23. https:\/\/doi.org\/10.1186\/ar2616 (2009).","journal-title":"Arthritis Res. Ther."},{"key":"75747_CR35","doi-asserted-by":"publisher","first-page":"17605","DOI":"10.1038\/srep17605","volume":"5","author":"J Li","year":"2015","unstructured":"Li, J. et al. Inhibition of Osteoclastogenesis and Bone Resorption in vitro and in vivo by a prenylflavonoid xanthohumol from hops. Sci. Rep. 5, 17605. https:\/\/doi.org\/10.1038\/srep17605 (2015).","journal-title":"Sci. Rep."},{"key":"75747_CR36","doi-asserted-by":"publisher","first-page":"2463","DOI":"10.1182\/blood-2017-08-801662","volume":"130","author":"PJ Lenting","year":"2017","unstructured":"Lenting, P. J., Denis, C. V. & Christophe, O. D. Emicizumab, a bispecific antibody recognizing coagulation factors IX and X: how does it actually compare to factor VIII? Blood. 130, 2463\u20132468. https:\/\/doi.org\/10.1182\/blood-2017-08-801662 (2017).","journal-title":"Blood"},{"key":"75747_CR37","doi-asserted-by":"publisher","first-page":"R152","DOI":"10.1186\/ar2046","volume":"8","author":"Y Komano","year":"2006","unstructured":"Komano, Y., Nanki, T., Hayashida, K., Taniguchi, K. & Miyasaka, N. Identification of a human peripheral blood monocyte subset that differentiates into osteoclasts. Arthritis Res. Ther. 8, R152. https:\/\/doi.org\/10.1186\/ar2046 (2006).","journal-title":"Arthritis Res. Ther."},{"key":"75747_CR38","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1136\/annrheumdis-2018-213250","volume":"77","author":"A Puchner","year":"2018","unstructured":"Puchner, A. et al. Non-classical monocytes as mediators of tissue destruction in arthritis. Ann. Rheum. Dis. 77, 1490\u20131497. https:\/\/doi.org\/10.1136\/annrheumdis-2018-213250 (2018).","journal-title":"Ann. Rheum. Dis."},{"key":"75747_CR39","doi-asserted-by":"publisher","first-page":"14428","DOI":"10.1038\/s41598-019-50787-9","volume":"9","author":"S Taves","year":"2019","unstructured":"Taves, S. et al. Hemophilia A and B mice, but not VWF(-\/-)mice, display bone defects in congenital development and remodeling after injury. Sci. Rep. 9, 14428. https:\/\/doi.org\/10.1038\/s41598-019-50787-9 (2019).","journal-title":"Sci. Rep."},{"key":"75747_CR40","doi-asserted-by":"publisher","first-page":"3551","DOI":"10.1002\/art.22175","volume":"54","author":"F De Benedetti","year":"2006","unstructured":"De Benedetti, F. et al. Impaired skeletal development in interleukin-6-transgenic mice: a model for the impact of chronic inflammation on the growing skeletal system. Arthritis Rheum. 54, 3551\u20133563. https:\/\/doi.org\/10.1002\/art.22175 (2006).","journal-title":"Arthritis Rheum."},{"key":"75747_CR41","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1111\/hae.14565","volume":"28","author":"D Citla-Sridhar","year":"2022","unstructured":"Citla-Sridhar, D., Sidonio, R. F., Ahuja, S. P. & Jr. & Bone health in haemophilia carriers and persons with Von Willebrand disease: a large database analysis. Haemophilia. 28, 671\u2013678. https:\/\/doi.org\/10.1111\/hae.14565 (2022).","journal-title":"Haemophilia"},{"key":"75747_CR42","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1002\/jbmr.4688","volume":"37","author":"J Pepe","year":"2022","unstructured":"Pepe, J. et al. Characterization of Extracellular vesicles in osteoporotic patients compared to osteopenic and healthy controls. J. Bone Min. Res. 37, 2186\u20132200. https:\/\/doi.org\/10.1002\/jbmr.4688 (2022).","journal-title":"J. Bone Min. Res."},{"key":"75747_CR43","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1002\/jcb.21331","volume":"102","author":"JM Hodge","year":"2007","unstructured":"Hodge, J. M., Kirkland, M. A. & Nicholson, G. C. Multiple roles of M-CSF in human osteoclastogenesis. J. Cell. Biochem. 102, 759\u2013768. https:\/\/doi.org\/10.1002\/jcb.21331 (2007).","journal-title":"J. Cell. Biochem."},{"key":"75747_CR44","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1002\/jcp.25220","volume":"231","author":"S Sprangers","year":"2016","unstructured":"Sprangers, S., Schoenmaker, T., Cao, Y., Everts, V. & de Vries, T. J. Different blood-borne human osteoclast precursors respond in distinct ways to IL-17A. J. Cell. Physiol. 231, 1249\u20131260. https:\/\/doi.org\/10.1002\/jcp.25220 (2016).","journal-title":"J. Cell. Physiol."},{"key":"75747_CR45","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1186\/s13075-020-02308-7","volume":"22","author":"J Xue","year":"2020","unstructured":"Xue, J. et al. CD14(+)CD16(-) monocytes are the main precursors of osteoclasts in rheumatoid arthritis via expressing Tyro3TK. Arthritis Res. Ther. 22, 221. https:\/\/doi.org\/10.1186\/s13075-020-02308-7 (2020).","journal-title":"Arthritis Res. Ther."},{"key":"75747_CR46","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1007\/s40265-019-01200-2","volume":"79","author":"HA Blair","year":"2019","unstructured":"Blair, H. A. & Emicizumab A review in Haemophilia A. Drugs. 79, 1697\u20131707. https:\/\/doi.org\/10.1007\/s40265-019-01200-2 (2019).","journal-title":"Drugs"},{"key":"75747_CR47","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/j.1756-185X.2009.01394.x","volume":"12","author":"H Mansouritorghabeh","year":"2009","unstructured":"Mansouritorghabeh, H. et al. Reduced bone density in individuals with severe hemophilia B. Int. J. Rheum. Dis. 12, 125\u2013129. https:\/\/doi.org\/10.1111\/j.1756-185X.2009.01394.x (2009).","journal-title":"Int. J. Rheum. Dis."},{"key":"75747_CR48","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/hae.12271","volume":"20","author":"P Anagnostis","year":"2014","unstructured":"Anagnostis, P. et al. The clinical utility of bone turnover markers in the evaluation of bone disease in patients with haemophilia A and B. Haemophilia. 20, 268\u2013275. https:\/\/doi.org\/10.1111\/hae.12271 (2014).","journal-title":"Haemophilia"},{"key":"75747_CR49","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1182\/bloodadvances.2018027557","volume":"3","author":"MN Weitzmann","year":"2019","unstructured":"Weitzmann, M. N. et al. Reduced bone formation in males and increased bone resorption in females drive bone loss in hemophilia A mice. Blood Adv. 3, 288\u2013300. https:\/\/doi.org\/10.1182\/bloodadvances.2018027557 (2019).","journal-title":"Blood Adv."},{"key":"75747_CR50","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1056\/NEJMoa0809493","volume":"361","author":"SR Cummings","year":"2009","unstructured":"Cummings, S. R. et al. Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N Engl. J. Med. 361, 756\u2013765. https:\/\/doi.org\/10.1056\/NEJMoa0809493 (2009).","journal-title":"N Engl. J. Med."},{"key":"75747_CR51","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/s8756-3282(03)00209-6","volume":"33","author":"CN Pagel","year":"2003","unstructured":"Pagel, C. N. et al. Inhibition of osteoblast apoptosis by thrombin. Bone. 33, 733\u2013743. https:\/\/doi.org\/10.1016\/s8756-3282(03)00209-6 (2003).","journal-title":"Bone"},{"key":"75747_CR52","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/0006-291x(89)91691-4","volume":"164","author":"DN Tatakis","year":"1989","unstructured":"Tatakis, D. N., Dolce, C. & Dziak, R. Thrombin\u2019s effects on osteoblastic cells. I. Cytosolic calcium and phosphoinositides. Biochem. Biophys. Res. Commun. 164, 119\u2013127. https:\/\/doi.org\/10.1016\/0006-291x(89)91691-4 (1989).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"75747_CR53","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1016\/j.biocel.2007.12.003","volume":"40","author":"EJ Mackie","year":"2008","unstructured":"Mackie, E. J. et al. Protease-activated receptors in the musculoskeletal system. Int. J. Biochem. Cell. Biol. 40, 1169\u20131184. https:\/\/doi.org\/10.1016\/j.biocel.2007.12.003 (2008).","journal-title":"Int. J. Biochem. Cell. Biol."},{"key":"75747_CR54","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1359\/JBMR.0301248","volume":"19","author":"R Smith","year":"2004","unstructured":"Smith, R. et al. Activation of protease-activated receptor-2 leads to inhibition of osteoclast differentiation. J. Bone Min. Res. 19, 507\u2013516. https:\/\/doi.org\/10.1359\/JBMR.0301248 (2004).","journal-title":"J. Bone Min. Res."},{"key":"75747_CR55","doi-asserted-by":"publisher","first-page":"5810","DOI":"10.1073\/pnas.86.15.5810","volume":"86","author":"RC Kowal","year":"1989","unstructured":"Kowal, R. C., Herz, J., Goldstein, J. L., Esser, V. & Brown, M. S. Low density lipoprotein receptor-related protein mediates uptake of cholesteryl esters derived from apoprotein E-enriched lipoproteins. Proc. Natl. Acad. Sci. U S A. 86, 5810\u20135814. https:\/\/doi.org\/10.1073\/pnas.86.15.5810 (1989).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"75747_CR56","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1152\/physrev.00033.2007","volume":"88","author":"AP Lillis","year":"2008","unstructured":"Lillis, A. P., Van Duyn, L. B., Murphy-Ullrich, J. E. & Strickland, D. K. LDL receptor-related protein 1: unique tissue-specific functions revealed by selective gene knockout studies. Physiol. Rev. 88, 887\u2013918. https:\/\/doi.org\/10.1152\/physrev.00033.2007 (2008).","journal-title":"Physiol. Rev."},{"key":"75747_CR57","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1111\/jth.15765","volume":"20","author":"M Sacco","year":"2022","unstructured":"Sacco, M. et al. The p.P1127S pathogenic variant lowers Von Willebrand factor levels through higher affinity for the macrophagic scavenger receptor LRP1: clinical phenotype and pathogenic mechanisms. J. Thromb. Haemost. 20, 1818\u20131829. https:\/\/doi.org\/10.1111\/jth.15765 (2022).","journal-title":"J. Thromb. Haemost"},{"key":"75747_CR58","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1182\/blood-2011-08-373605","volume":"119","author":"G Rastegarlari","year":"2012","unstructured":"Rastegarlari, G. et al. Macrophage LRP1 contributes to the clearance of Von Willebrand factor. Blood. 119, 2126\u20132134. https:\/\/doi.org\/10.1182\/blood-2011-08-373605 (2012).","journal-title":"Blood"},{"key":"75747_CR59","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1016\/j.bbrc.2020.01.065","volume":"523","author":"Y Kohara","year":"2020","unstructured":"Kohara, Y., Haraguchi, R., Kitazawa, R. & Kitazawa, S. Knockdown of Lrp1 in RAW264 cells inhibits osteoclast differentiation and osteoclast-osteoblast interactions in vitro. Biochem. Biophys. Res. Commun. 523, 961\u2013965. https:\/\/doi.org\/10.1016\/j.bbrc.2020.01.065 (2020).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"75747_CR60","doi-asserted-by":"publisher","first-page":"8695","DOI":"10.1016\/S0021-9258(19)84436-8","volume":"261","author":"J Jesty","year":"1986","unstructured":"Jesty, J. Analysis of the generation and inhibition of activated coagulation factor X in pure systems and in human plasma. J. Biol. Chem. 261, 8695\u20138702 (1986).","journal-title":"J. Biol. Chem."},{"key":"75747_CR61","doi-asserted-by":"publisher","first-page":"9225","DOI":"10.1038\/s41598-023-47694-5","volume":"14","author":"ID Tarandovskiy","year":"2024","unstructured":"Tarandovskiy, I. D. et al. Investigation of thrombin concentration at the time of clot formation in simultaneous thrombin and fibrin generation assays. Sci. Rep. 14, 9225. https:\/\/doi.org\/10.1038\/s41598-023-47694-5 (2024).","journal-title":"Sci. Rep."},{"key":"75747_CR62","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1182\/blood-2008-01-133181","volume":"112","author":"CJ van Schooten","year":"2008","unstructured":"van Schooten, C. J. et al. Macrophages contribute to the cellular uptake of Von Willebrand factor and factor VIII in vivo. Blood. 112, 1704\u20131712. https:\/\/doi.org\/10.1182\/blood-2008-01-133181 (2008).","journal-title":"Blood"},{"key":"75747_CR63","doi-asserted-by":"publisher","first-page":"6320","DOI":"10.1038\/s41467-022-33796-7","volume":"13","author":"C Drakeford","year":"2022","unstructured":"Drakeford, C. et al. Von Willebrand factor links primary hemostasis to innate immunity. Nat. Commun. 13, 6320. https:\/\/doi.org\/10.1038\/s41467-022-33796-7 (2022).","journal-title":"Nat. Commun."},{"key":"75747_CR64","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1111\/j.1538-7836.2007.02591.x","volume":"5","author":"Y Repesse","year":"2007","unstructured":"Repesse, Y. et al. Factor VIII (FVIII) gene mutations in 120 patients with hemophilia A: detection of 26 novel mutations and correlation with FVIII inhibitor development. J. Thromb. Haemost. 5, 1469\u20131476. https:\/\/doi.org\/10.1111\/j.1538-7836.2007.02591.x (2007).","journal-title":"J. Thromb. Haemost"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-75747-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-75747-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-75747-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T04:11:22Z","timestamp":1729656682000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-75747-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,23]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["75747"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-75747-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4692623\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,23]]},"assertion":[{"value":"5 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved after a full ethical review by the Institutional Review Board (IRB) of the Fondazione Policlinico Universitario \u201cA. Gemelli\u201d IRCCS (Lazio Roma 3, approval #22082) and IRB of the Bambino Ges\u00f9 Children\u2019s Hospital (approval #2426_OPBG_2021). The data were accessed anonymously.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Institutional review board approval"}}],"article-number":"25001"}}